In clear cell renal cell carcinoma (ccRCC), SETD2 is the second most frequently mutated gene, contributing to 10 to 15% of all ccRCC cases (6, 13, 14, 15, 16). Here, SETD2 is linked to nonpapillary renal cell carcinoma.